One suspected reaction, noticed by one nurse in one district hospital. You will carry it the whole way — to the hospital's ADR Monitoring Centre, on to the National Coordination Centre at the Indian Pharmacopoeia Commission, and into VigiBase at the Uppsala Monitoring Centre in Sweden, where the world's safety data lives. Every decision you make survives to the next stage. Some of them decide whether the report was worth making at all.
| Competency | Marks |
|---|---|
| Recognising a reportable reaction and acting on it | 10 |
| Securing the four minimum elements of a valid case | 15 |
| Completing the reporting form accurately | 10 |
| Seriousness and causality at the AMC | 10 |
| Identifying what follow-up the case needs | 10 |
| MedDRA and WHODrug coding | 20 |
| Duplicate handling and onward transmission | 10 |
| Reading the global data — signal, not proof | 10 |
| Closing the loop back to the reporter | 5 |
| Total | 100 |
Staff Nurse Reshma stops you in the corridor. She is not sure this is anything.
You are now the Pharmacovigilance Associate. The form in front of you is the Suspected Adverse Drug Reaction Reporting Form used across the Pharmacovigilance Programme of India.
The case has arrived from your AMC along with several hundred others this week. Before it can go anywhere it has to be turned from words into data.
Carry the report all the way to Uppsala and close the loop to see the debrief.
Your report writer opens once you finish the case.